Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy
Gerhard Pütz; Oliver Schmah; Jürgen Eckes; Martin J. Hug; Karl Winkler
- 作者Gerhard Pütz; Oliver Schmah; Jürgen Eckes; Martin J. Hug; Karl Winkler
- 卷第72卷
- 期第4期
- 印刷ISSN0306-9877
- 文件大小132.32KB
- 发表时间2009
- DOI10.1016/j.mehy.2008.11.027